Comorbid Aβ toxicity and stroke: Hippocampal atrophy, pathology, and cognitive deficit

Neurobiology of Aging

Volumn 35, Issue 7, 2014, Pages 1605-1614

  Amtul, Zareen ^a   Nikolova, Simona ^b   Gao, Lulu ^c   Keeley, Robin J ^d   Bechberger, John F ^e   Fisher, Alicia L ^d   Bartha, Robert ^b   Munoz, David G ^f   McDonald, Robert J ^d   Naus, Christian C ^e   Wojtowicz, J Martin ^c   Hachinski, Vladimir ^g   Cechetto, David F ^a  

^a WESTERN UNIVERSITY   (Canada)

^b ROBARTS RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF LETHBRIDGE   (Canada)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^f ST MICHAEL'S HOSPITAL   (Canada)

^g LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

amyloid; Axonal retraction; Fear conditioning; Neurogenesis; Stroke

Indexed keywords

AMYLOID BETA PROTEIN; CONNEXIN 43;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ATROPHY; CELL COUNT; CELL STRUCTURE; CELL SURVIVAL; CEREBROVASCULAR ACCIDENT; COGNITIVE DEFECT; COMORBIDITY; CONTROLLED STUDY; DENTATE GYRUS; GLIOSIS; HIPPOCAMPUS; LEARNING DISORDER; MALE; MICROGLIA; NERVE CELL DEGENERATION; NERVE CELL DIFFERENTIATION; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT;

AXONAL RETRACTION; FEAR CONDITIONING; NEUROGENESIS; STROKE; Β-AMYLOID;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; ATROPHY; CONNEXIN 43; DEMENTIA; DISEASE MODELS, ANIMAL; ENDOTHELIN-1; HIPPOCAMPUS; HUMANS; INJECTIONS, INTRAVENTRICULAR; MALE; STROKE; VASOCONSTRICTOR AGENTS;

EID: 84903365872     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2014.01.005     Document Type: Article

References (51)

1. Akama K.T., Albanese C., Pestell R.G., Van Eldik L.J. Amyloid beta-peptide stimulates nitric oxide production in astrocytes through an NFkappaB-dependent mechanism. Proc. Natl. Acad. Sci. U.S.A 1998, 95:5795-5800.
2. Amtul Z., Whitehead, S., Keeley, R.J., Bechberger J.F., McDonald, R.J., Naus, C., Cechetto, D.F., 2014. Co-morbid rat model of ischemia and β-amyloid toxicity: striatal and cortical degeneration. 1-28.
3. Antoniadis E.A., McDonald R.J. Amygdala, hippocampus and discriminative fear conditioning to context. Behav. Brain Res. 2000, 108:1-19.
4. Bales K.R., Du Y., Holtzman D., Cordell B., Paul S.M. Neuroinflammation and Alzheimer's disease: critical roles for cytokine/Abeta-induced glial activation, NF-kappaB, and apolipoprotein E. Neurobiol. Aging 2000, 21:427-432.
5. Bitting L., Naidu A., Cordell B., Murphy G.M. Beta-amyloid peptide secretion by a microglial cell line is induced by beta-amyloid-(25-35) and lipopolysaccharide. J.Biol. Chem. 1996, 271:16084-16089.
6. Boucsein C., Kettenmann H., Nolte C. Electrophysiological properties of microglial cells in normal and pathologic rat brain slices. Eur. J. Neurosci. 2000, 12:2049-2058.
7. Centonze D., Finazzi-Agro A., Bernardi G., Maccarrone M. The endocannabinoid system in targeting inflammatory neurodegenerative diseases. Trends Pharmacol. Sci. 2007, 28:180-187.
8. Cheng G., Whitehead S.N., Hachinski V., Cechetto D.F. Effects of pyrrolidine dithiocarbamate on beta-amyloid (25-35)-induced inflammatory responses and memory deficits in the rat. Neurobiol. Dis. 2006, 23:140-151.
9. Damjanac M., Rioux B.A., Barrier L., Pontcharraud R., Anne C., Hugon J., Page G. Fluoro-Jade B staining as useful tool to identify activated microglia and astrocytes in a mouse transgenic model of Alzheimer's disease. Brain Res. 2007, 1128:40-49.
10. Gould E., Beylin A., Tanapat P., Reeves A., Shors T.J. Learning enhances adult neurogenesis in the hippocampal formation. Nat. Neurosci. 1999, 2:260-265.
11. Hachinski V., Munoz D. Vascular factors in cognitive impairment-where are we now?. Ann. N. Y. Acad. Sci. 2000, 903:1-5.
12. Heyman A., Fillenbaum G.G., Welsh-Bohmer K.A., Gearing M., Mirra S.S., Mohs R.C., Peterson B.L., Pieper C.F. Cerebral infarcts in patients with autopsy-proven Alzheimer's disease: CERAD, part XVIII. Consortium to Establish a Registry for Alzheimer's Disease. Neurology 1998, 51:159-162.
13. Hu J., Van Eldik L.J. Glial-derived proteins activate cultured astrocytesand enhance beta amyloid-induced glial activation. Brain Res. 1999, 842:46-54.
14. Kalaria R.N. Cerebrovascular degeneration is related to amyloid-beta protein deposition in Alzheimer's disease. Ann. N. Y. Acad. Sci. 1997, 826:263-271.
15. Kalaria R.N., Bhatti S.U., Palatinsky E.A., Pennington D.H., Shelton E.R., Chan H.W., Perry G., Lust W.D. Accumulation of the beta amyloid precursor protein at sites of ischemic injury in rat brain. Neuroreport 1993, 4:211-214.
16. Kaneko I., Morimoto K., Kubo T. Drastic neuronal loss invivo by beta-amyloid racemized at Ser(26) residue: conversion of non-toxic [D-Ser(26)]beta-amyloid 1-40 to toxic and proteinase-resistant fragments. Neuroscience 2001, 104:1003-1011.
17. Klunk W.E., Price J.C., Mathis C.A., Tsopelas N.D., Lopresti B.J., Ziolko S.K., Bi W., Hoge J.A., Cohen A.D., Ikonomovic M.D., Saxton J.A., Snitz B.E., Pollen D.A., Moonis M., Lippa C.F., Swearer J.M., Johnson K.A., Rentz D.M., Fischman A.J., Aizenstein H.J., Dekosky S.T. Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees. J.Neurosci. 2007, 27:6174-6184.
18. Kubo T., Nishimura S., Kumagae Y., Kaneko I. Invivo conversion of racemized beta-amyloid ([D-Ser 26]A beta 1-40) to truncated and toxic fragments ([D-Ser 26]A beta 25-35/40) and fragment presence in the brains of Alzheimer's patients. J.Neurosci. Res. 2002, 70:474-483.
19. Levin E.R. Endothelins. N.Engl. J. Med. 1995, 333:356-363.
20. Leys D., Henon H., kowiak-Cordoliani M.A., Pasquier F. Poststroke dementia. Lancet Neurol. 2005, 4:752-759.
21. Malm T., Ort M., Tahtivaara L., Jukarainen N., Goldsteins G., Puolivali J., Nurmi A., Pussinen R., Ahtoniemi T., Miettinen T.K., Kanninen K., Leskinen S., Vartiainen N., Yrjanheikki J., Laatikainen R., Harris-White M.E., Koistinaho M., Frautschy S.A., Bures J., Koistinaho J. Beta-amyloid infusion results in delayed and age-dependent learning deficits without role of inflammation or beta-amyloid deposits. Proc. Natl. Acad. Sci. U.S.A 2006, 103:8852-8857.
22. Marchalant Y., Brothers H.M., Norman G.J., Karelina K., DeVries A.C., Wenk G.L. Cannabinoids attenuate the effects of aging upon neuroinflammation and neurogenesis. Neurobiol. Dis. 2009, 34:300-307.
23. Mei X., Ezan P., Giaume C., Koulakoff A. Astroglial connexin immunoreactivity is specifically altered at beta-amyloid plaques in beta-amyloid precursor protein/presenilin1 mice. Neuroscience 2010, 171:92-105.
24. Moller J.C., Klein M.A., Haas S., Jones L.L., Kreutzberg G.W., Raivich G. Regulation of thrombospondin in the regenerating mouse facial motor nucleus. Glia 1996, 17:121-132.
25. Moser M.B., Moser E.I., Forrest E., Andersen P., Morris R.G. Spatial learning with a minislab in the dorsal hippocampus. Proc. Natl. Acad. Sci. U.S.A 1995, 92:9697-9701.
26. Nagy J.I., Li W., Hertzberg E.L., Marotta C.A. Elevated connexin43 immunoreactivity at sites of amyloid plaques in Alzheimer's disease. Brain Res. 1996, 717:173-178.
27. Nestor S.M., Rupsingh R., Borrie M., Smith M., Accomazzi V., Wells J.L., Fogarty J., Bartha R. Ventricular enlargement as a possible measure of Alzheimer's disease progression validated using the Alzheimer's disease neuroimaging initiative database. Brain 2008, 131:2443-2454.
28. Nogawa S., Zhang F., Ross M.E., Iadecola C. Cyclo-oxygenase-2 gene expression in neurons contributes to ischemic brain damage. J.Neurosci. 1997, 17:2746-2755.
29. Orellana J.A., Shoji K.F., Abudara V., Ezan P., Amigou E., Saez P.J., Jiang J.X., Naus C.C., Saez J.C., Giaume C. Amyloid beta-induced death in neurons involves glial and neuronal hemichannels. J.Neurosci. 2011, 31:4962-4977.
30. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 1986, Academic Press, Inc, San Diego, CA.
31. Pooler A.M., Arjona A.A., Lee R.K., Wurtman R.J. Prostaglandin E2 regulates amyloid precursor protein expression via the EP2 receptor in cultured rat microglia. Neurosci. Lett. 2004, 362:127-130.
32. Raivich G., Haas S., Werner A., Klein M.A., Kloss C., Kreutzberg G.W. Regulation of MCSF receptors on microglia in the normal and injured mouse central nervous system: a quantitative immunofluorescence study using confocal laser microscopy. J.Comp. Neurol. 1998, 395:342-358.
33. Rosenzweig S., Wojtowicz J.M. Analyzing dendritic growth in a population of immature neurons in the adult dentate gyrus using laminar quantification of disjointed dendrites. Front Neurosci. 2011, 5:34.
34. Schmued L.C., Albertson C., Slikker W. Fluoro-Jade: a novel fluorochrome for the sensitive and reliable histochemical localization of neuronal degeneration. Brain Res. 1997, 751:37-46.
35. Schneider J.A., Boyle P.A., Arvanitakis Z., Bienias J.L., Bennett D.A. Subcortical infarcts, Alzheimer's disease pathology, and memory function in older persons. Ann. Neurol. 2007, 62:59-66.
36. Sigurdsson E.M., Lee J.M., Dong X.W., Hejna M.J., Lorens S.A. Bilateral injections of amyloid-beta 25-35 into the amygdala of young Fischer rats: behavioral, neurochemical, and time dependent histopathological effects. Neurobiol. Aging 1997, 18:591-608.
37. Snowdon D.A., Greiner L.H., Mortimer J.A., Riley K.P., Greiner P.A., Markesbery W.R. Brain infarction and the clinical expression ofAlzheimer disease. The Nun Study. J.Am. Med. Assoc. 1997, 277:813-817.
38. Snyder J.S., Hong N.S., McDonald R.J., Wojtowicz J.M. Arole for adultneurogenesis in spatial long-term memory. Neuroscience 2005, 130:843-852.
39. Souza A.C., Sari M.H., Pinton S., Luchese C., Neto J.S., Nogueira C.W. 2-Phenylethynyl-butyltellurium attenuates amyloid-beta peptide(25-35)-induced learning and memory impairments in mice. J.Neurosci. Res. 2013, 91:848-853.
40. Stoll G., Jander S., Schroeter M. Inflammation and glial responses in ischemic brain lesions. Prog. Neurobiol. 1998, 56:149-171.
41. Streit W.J., Graeber M.B., Kreutzberg G.W. Functional plasticity of microglia: a review. Glia 1988, 1:301-307.
42. Thompson P.M., Hayashi K.M., De Zubicaray G.I., Janke A.L., Rose S.E., Semple J., Hong M.S., Herman D.H., Gravano D., Doddrell D.M., Toga A.W. Mapping hippocampal and ventricular change in Alzheimer disease. Neuroimage 2004, 22:1754-1766.
43. Vermeer S.E., Prins N.D., den H.T., Hofman A., Koudstaal P.J., Breteler M.M. Silent brain infarcts and the risk of dementia and cognitive decline. N.Engl. J. Med. 2003, 348:1215-1222.
44. Verret L., Trouche S., Zerwas M., Rampon C. Hippocampal neurogenesis during normal and pathological aging. Psychoneuroendocrinology 2007, 32(suppl 1):S26-S30.
45. Waddell J., Shors T.J. Neurogenesis, learning and associative strength. Eur. J. Neurosci. 2008, 27:3020-3028.
46. West M.J. Introduction to stereology. Cold Spring Harb. Protoc. 2012, 843-851.
47. Whitehead S.N., Cheng G., Hachinski V.C., Cechetto D.F. Progressive increase in infarct size, neuroinflammation, and cognitive deficits in the presence of high levels of amyloid. Stroke 2007, 38:3245-3250.
48. Whitehead S.N., Hachinski V.C., Cechetto D.F. Interaction between a rat model of cerebral ischemia and beta-amyloid toxicity: inflammatory responses. Stroke 2005, 36:107-112.
49. Winocur G., Wojtowicz J.M., Sekeres M., Snyder J.S., Wang S. Inhibition of neurogenesis interferes with hippocampus-dependent memory function. Hippocampus 2006, 16:296-304.
50. Zipp F., Aktas O. The brain as a target of inflammation: common pathways link inflammatory and neurodegenerative diseases. Trends Neurosci. 2006, 29:518-527.
51. Zussy C., Brureau A., Keller E., Marchal S., Blayo C., Delair B., Ixart G., Maurice T., Givalois L. Alzheimer's disease related markers, cellular toxicity and behavioral deficits induced six weeks after oligomeric amyloid-beta peptide injection in rats. PLoS One 2013, 8:e53117.